CRON News

TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos’ borderless product strategy, expanding the Company’s globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world.

DUBLIN--(BUSINESS WIRE)--The "United States Cannabis Market - Legalization Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Cannabis Market is expected to reach US$ 91.10 billion by 2033 from US$ 36.94 billion in 2024, with a CAGR of 10.55% from 2025 to 2033 Increased state-by-state legalization, an increase in medical applications, consumer acceptance, product innovation, growing retail infrastructure, investment inflows, favorable regu

Net revenue in Q2 2025 increased by 21% year-over-year

Canary Capital Group LLC is looking to introduce a new level of accessibility and framework to crypto investing by means of a recently submitted S-1 registration statement to the U.S. Securities and Exchange Commission.

Cronos reported first-quarter revenue of $32.26 million, beating analyst estimates of $31.70 million, according to Benzinga Pro. The company reported first-quarter earnings of 2 cents per share, beating estimates for a loss of 1 cent per share.

Cronos' Q4 sales rose to $30.3M but missed estimates. Gross profit surged, and adjusted EBITDA loss improved as the company eyes long-term growth.

Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook.

Cronos CEO Mike Gorenstein discusses Trump's potential for cannabis reform, challenges the "blue state" myth, and Cronos' focus...